Winrevair, also known as sotatercept-csrk, is a medicine used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the arteries that go from your heart to your lungs.
By the end of August, Heidi had a confirmed diagnosis of pulmonary arterial hypertension (PAH), a specific type of pulmonary hypertension that affects the arteries of the lungs and strains the right ...
Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...
As the world marks Rare Disease Month, health experts are calling attention to conditions that often go unnoticed—despite their life-threatening impact. One such condition is Pulmonary Arterial ...
In the 1980s, when Stella Kourembanas, MD, began her career in neonatology, she cared for newborns with pulmonary hypertension, a disease that results in abnormally high blood pressure in the lung ...
Pulmonary arterial hypertension (PAH) is a rare condition that's difficult to treat. The hallmarks of the disease—narrowing of the arterioles and capillaries that deliver blood to the lungs—force the ...
I woke up one morning and couldn't walk. I looked at my husband and said, "I need to go to the hospital." ...
Post-transplant lymphoproliferative disorder 1.6 2.1 Other 1 1.3 Adapted with permission from [20]. † Patients with poor hemodynamics at presentation can respond well to iv. epoprostenol. Patients ...
Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension appears in 25% to 30% of patients with COPD. There are no approved therapies for patients ...
Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries that go from your heart to your lungs. It happens when these arteries become narrow or blocked, making it harder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results